The purpose of this work was to investigate the susceptibility of an aluminum adjuvant and
an aluminum-adjuvanted native outer membrane vesicle (nOMV) vaccine formulation to …

A replication-deficient lentiviral vector encoding the tumor antigen gene NY-ESO-1 was
characterized in terms of vector morphology, particle size range, concentration, and zeta …

Freezing and thawing of vaccines containing aluminum adjuvants can lead to formation of
aggregates and loss in vaccine potency. We sought to understand whether and to what …

Two enveloped viral vectors, vesicular stomatitis virus and influenza virus, and a non-
enveloped viral vector, human adenovirus type 5, were encapsulated by spray drying to …

Vaccine sedimentation and resuspension are properties that vaccine makers use to
characterize a suspension product during research and development as well as throughout …

Adjuvants are often included in vaccine formulations to enhance and modulate immune
responses against pathogenic antigens. Aluminum-based adjuvants are prepared as …

Purpose To evaluate w NMR, an emerging noninvasive analytical technology, for
characterizing aluminum-adjuvanted vaccine formulations. Methods w NMR stands for water …

The development of nonviral vectors as commercial therapeutics will require formulations
that are sufficiently stable to allow shipping and storage for prolonged periods. Given the …

Virus-like particles (VLPs) have been extensively explored as vaccine candidates since the
mid-1980s. Numerous VLPs have been designed as vaccines for prevention of virus …

Vaccines used for managing Newcastle disease virus (NDV) rely heavily on cold chain, and
this results in major constraints in their successful application, shipping, and storage. This …